A paper published in Biology Methods and Protocols, indicates that a new computational method may help researchers identify ...
Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...
CompagOS has produced biologically reproducible Bon3OID™ bone models using 3D bioprinting. Find out more in the interview!
IT Solutions, a premier managed service provider serving organizations across the United States and Canada, announced today ...
DLG (Digital Luxury Group) today announces LuxuryIQ MCP, the first Model Context Protocol integration designed specifically for the luxury industry.The integration gives luxury executives ...
Belite Bio completes enrollment in phase 2/3 DRAGON II clinical trial evaluating tinlarebant for the treatment of Stargardt ...
Q2 2026 Earnings Call February 4, 2026 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...
Fibrosis, characterized by excessive extracellular matrix accumulation and disrupted tissue architecture, is an area where TB-4 has attracted significant attention. Investigations purport that TB-4 ...
The year 2026 stands as a testament to the power of vision, resilience, and purposeful leadership, shaped by individuals who ...
DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- The global pharmaceutical supply chain is currently ...
Rare disease clinical trials are smaller and often use surrogate endpoints, reducing costs but posing unique operational ...
The NEWHEART projects develop a new treatment option after heart attacks / ERC funding of 150,000 euros over 18 months allows researchers to explore the commercial or societal potential of their work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results